Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Sep;95(1):218–224. doi: 10.1111/j.1476-5381.1988.tb16567.x

Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels.

P Soares-da-Silva 1
PMCID: PMC1854135  PMID: 2905904

Abstract

1. The overflow of dopamine and noradrenaline (NA) from the main trunk of the dog mesenteric artery and its proximal branches during prolonged depolarization (120 min) by K+ (52 mM) was quantified by high performance liquid chromatography with electrochemical detection. 2. K+-induced depolarization resulted in release of both dopamine and NA. The amount of NA released from both blood vessels declined progressively throughout the experiment. In the main trunk the same pattern of release was observed for dopamine, whereas in the proximal branches the overflow of dopamine increased throughout the experiment. 3. The addition of phentolamine (0.2 microM) to the perifusion fluid increased the overflow of both amines. In the presence of sulpiride (1 microM) the overflow of dopamine and NA was found to be increased in the proximal branches, but not in the main trunk. The addition of phentolamine to sulpiride caused a further increase in amine overflow in proximal branches, but not in the main trunk. 4. The addition of alpha-methyl-p-tyrosine (50 microM) to the perifusion fluid caused a decrease in the amounts of dopamine and NA released from both preparations. In alpha-methyl-p-tyrosine-treated preparations phentolamine increased amine overflow to the same extent as in experiments without tyrosine hydroxylase inhibition. The increasing effect of sulpiride on the overflow of dopamine and NA from the proximal branches was completely abolished after alpha-methyl-p-tyrosine. 5. The results presented suggest that in the proximal branches of the dog mesenteric artery, dopamine beta-hydroxylase represents a rate limiting step in the synthesis of NA; dopamine, through activation of prejunctional dopamine receptors acts like a prejunctional co-transmitter in the control of transmitter release, but only newly-synthesized dopamine appears to be responsible for this effect.

Full text

PDF
218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azevedo I., Soares-da-Silva P. Are fibroblasts adrenergically innervated cells? Blood Vessels. 1981;18(6):330–332. doi: 10.1159/000158366. [DOI] [PubMed] [Google Scholar]
  2. Basbaum C. B., Heuser J. E. Morphological studies of stimulated adrenergic axon varicosities in the mouse vas deferens. J Cell Biol. 1979 Feb;80(2):310–325. doi: 10.1083/jcb.80.2.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell C., Gillespie J. S., Macrae I. M. Release of noradrenaline and dopamine by nerve stimulation in the guinea-pig and rat vas deferens. Br J Pharmacol. 1984 Mar;81(3):563–569. doi: 10.1111/j.1476-5381.1984.tb10110.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradley T., Hjemdahl P. Further studies on renal nerve stimulation induced release of noradrenaline and dopamine from the canine kidney in situ. Acta Physiol Scand. 1984 Nov;122(3):369–379. doi: 10.1111/j.1748-1716.1984.tb07521.x. [DOI] [PubMed] [Google Scholar]
  5. Enero M. A., Langer S. Z. Influence of reserpine-induced depletion of noradrenaline on the negative feed-back mechanism for transmitter release during nerve stimulation. Br J Pharmacol. 1973 Oct;49(2):214–225. doi: 10.1111/j.1476-5381.1973.tb08367.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1980 Dec;32(4):337–362. [PubMed] [Google Scholar]
  7. Lokhandwala M. F., Barrett R. J. Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. J Auton Pharmacol. 1982 Sep;2(3):189–215. doi: 10.1111/j.1474-8673.1982.tb00489.x. [DOI] [PubMed] [Google Scholar]
  8. Matta R. J., Wooten G. F. Pharmacology of fusaric acid in man. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):541–546. doi: 10.1002/cpt1973144part1541. [DOI] [PubMed] [Google Scholar]
  9. Muller B. D., Bell C. Vesicular storage of 3,4-dihydroxyphenylethylamine and noradrenaline in terminal sympathetic nerves of dog spleen and kidney. J Neurochem. 1986 Nov;47(5):1370–1375. doi: 10.1111/j.1471-4159.1986.tb00767.x. [DOI] [PubMed] [Google Scholar]
  10. Neuman B., Wiedermann C. J., Fischer-Colbrie R., Schober M., Sperk G., Winkler H. Biochemical and functional properties of large and small dense-core vesicles in sympathetic nerves of rat and ox vas deferens. Neuroscience. 1984 Nov;13(3):921–931. doi: 10.1016/0306-4522(84)90106-4. [DOI] [PubMed] [Google Scholar]
  11. Ohlstein E. H., Kruse L. I., Ezekiel M., Sherman S. S., Erickson R., DeWolf W. E., Jr, Berkowitz B. A. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1987 May;241(2):554–559. [PubMed] [Google Scholar]
  12. Soares-da-Silva P. A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery. Br J Pharmacol. 1987 Jan;90(1):91–98. doi: 10.1111/j.1476-5381.1987.tb16828.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Soares-da-Silva P., Azevedo I. Fibroblasts and sympathetic innervation of blood vessels. Blood Vessels. 1985;22(6):278–285. doi: 10.1159/000158614. [DOI] [PubMed] [Google Scholar]
  14. Soares-da-Silva P., Davidson R. Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool. Naunyn Schmiedebergs Arch Pharmacol. 1985 May;329(3):253–257. doi: 10.1007/BF00501876. [DOI] [PubMed] [Google Scholar]
  15. Soares-da-Silva P. Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels. Br J Pharmacol. 1987 Jul;91(3):591–599. doi: 10.1111/j.1476-5381.1987.tb11252.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Soares-da-Silva P. Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):219–223. doi: 10.1007/BF00512932. [DOI] [PubMed] [Google Scholar]
  17. Starke K. Presynaptic alpha-autoreceptors. Rev Physiol Biochem Pharmacol. 1987;107:73–146. [PubMed] [Google Scholar]
  18. Willems J. L., Buylaert W. A., Lefebvre R. A., Bogaert M. G. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev. 1985 Jun;37(2):165–216. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES